Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000006467 | SCV001381188 | likely pathogenic | Holoprosencephaly 2 | 2019-08-02 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with proline at codon 257 of the SIX3 protein (p.Arg257Pro). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and proline. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individuals affected with holoprosencephaly (PMID: 10369266, Invitae). In at least one individual the data is consistent with the variant being de novo. ClinVar contains an entry for this variant (Variation ID: 6094). This variant has been reported to have conflicting or insufficient data to determine the effect on SIX3 protein function using different gene targets (PMID:15523651, 19346217). This variant disrupts the p.Arg257 amino acid residue in SIX3. Other variant(s) that disrupt this residue have been observed in individuals with SIX3-related conditions (PMID:20531442, 15221788, 18791198), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
OMIM | RCV000006467 | SCV000026650 | pathogenic | Holoprosencephaly 2 | 2004-12-01 | no assertion criteria provided | literature only | |
Gene |
RCV000006467 | SCV000086607 | pathologic | Holoprosencephaly 2 | 2013-08-29 | no assertion criteria provided | curation | Converted during submission to Pathogenic. |